Tandem Diabetes Care (TNDM) Amortizatization of Intangibles (2020 - 2021)
Tandem Diabetes Care's (TNDM) quarterly Amortizatization of Intangibles came in at -$223000.0 in Q3 2021, down 169.91% YoY from $319000.0 in Q3 2020, and down 169.91% on a QoQ basis from $319000.0 in Q3 2020.
Tandem Diabetes Care (TNDM) Amortizatization of Intangibles (2020 - 2021) Analysis & Trends
Tandem Diabetes Care (TNDM) has 2 years of Amortizatization of Intangibles data on file, last reported at -$223000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -223,000.00 |
| Sep 30, 2021 | -223,000.00 |
| Sep 30, 2020 | 319,000.00 |
| Sep 30, 2020 | 319,000.00 |